News | News By Subject | News by Disease News By Date | Search News

Diabetes, Type 2 (non-insulin dependent) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Agreement Reached After Novo Nordisk A/S (NVO) is Accused of Disguising Salespeople and Dealing Kickbacks     5/2/2017
This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S (NVO)     3/10/2017
Pfizer (PFE) Quietly Kills 3 Pipeline Programs     2/2/2017
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square     9/13/2016
With Hopes of Bolstering Sanofi (SNY)’s Sagging Diabetes Sector, Announces FDA Approval of Adlyxin in U.S.     7/28/2016
FDA Panel Narrowly Backs Cardiovascular Claims for Boehringer Ingelheim, Eli Lilly (LLY)'s Jardiance     6/29/2016
Sanofi (SNY)'s New Diabetes Combo Nails Late-Stage Goals     6/13/2016
Sanofi (SNY) Snags FDA Panel's Support for New Once-Daily Diabetes Combo iGlarLixi     5/26/2016
Oramed (ORMP)'s Oral Insulin Succeeds In Phase IIb Type 2 Diabetes Trial     5/18/2016
Intarcia Touts Large Phase III Trial Diabetes Data, Bags $75 Million     5/6/2016
Eli Lilly (LLY) Abandons Development of Transition Therapeutics (TTH.TO)' Diabetes Candidate TT401     4/19/2016
Sanofi (SNY) Pays $20 Million Milestone and Redeems Priority Review Voucher for Zealand Pharma  (ZEAL.CO)’s LixiLan     12/23/2015
FDA Clears Eli Lilly (LLY)'s Diabetes Drug Basaglar     12/17/2015
Biodel (BIOD) Announces Removal of Partial FDA Clinical Hold on Phase IIb Study 3-250     10/12/2015
SoCal's Elcelyx Therapeutics Reels in $40 Million     10/1/2015

News from Around the Web
FDA Warns of Leg, Foot Amputations With Johnson & Johnson (JNJ)'s Diabetes Med, Invokana     5/17/2017
New Test IDs Diabetics Who Are At High Risk Of Kidney Failure, Joslin Diabetes Center Study Reveals     4/19/2017
Bay Area's Livongo Rakes in $52.5 Million     3/17/2017
Long Naps Linked To Diabetes, University of Tokyo Study     9/15/2016
Early And Late Menopause Can Increase Risk Of Type 2 Diabetes, Kaiser Permanente Study     7/27/2016
Cycling May Help Lower Type 2 Diabetes Risk, University Of Southern Denmark Study     7/13/2016
Sex Could Play A Role In Type 2 Diabetes Treatment... But Not In The Way You Think, IRCM Study     7/6/2016
Gray Matter Changes In Brains Of Teenagers With Type 2 Diabetes, Cincinnati Children's Hospital Medical Center Scientists Reveal     6/15/2016
GI Windows Anastomosis System For Treating Type 2 Diabetes     6/2/2016
Eating Junk Food Just As Harmful To Kidneys As Diabetes, Anglia Ruskin University Study     5/10/2016
More Blood Vessels In Adipose Tissue May Alleviate Type 2 Diabetes, University of Helsinki Study     4/25/2016
How Depression May Boost Your Type 2 Diabetes Risk, McGill University Study     4/15/2016
Long Naps, Daytime Sleepiness Tied To Heart Risks, University of Tokyo Reveals     3/28/2016
Thirdhand Smoke Doubles Your Diabetes Risk, University of California, Riverside Study     3/3/2016
Molecular Link Between Psychiatric Disorders And Type 2 Diabetes Discovered, University of Massachusetts Medical School Scientists Reveal     2/8/2016

Press Releases
Novo Nordisk A/S (NVO) Receives Positive 17-2 Vote From FDA Advisory Committee That Victoza Provides Substantial Evidence Of Cardiovascular Risk Reduction In Patients With Type 2 Diabetes     6/21/2017
twoXAR Announces Preclinical Proof-Of-Concept Data On Type 2 Diabetes Candidate     6/20/2017
Eli Lilly (LLY) Release: Jardiance (empagliflozin) Analysis Reinforces Established Safety Profile     6/14/2017
American Diabetes Association Release: Daily, Long-Acting Oral Insulin Tablet Provides Comparable Glycemic Control To Insulin Glargine Injection In Patients With Type 2 Diabetes     6/14/2017
American Diabetes Association Release: Major Study Heralds New Era In Treatment Of Type 2 Diabetes     6/13/2017
American Diabetes Association Release: New, Long-Acting Insulin Therapy Demonstrates Cardiovascular Safety And Reduces The Risk Of Severe Hypoglycemia     6/13/2017
Merck & Co. (MRK), Pfizer (PFE)'s New Diabetes Med Met Primary Endpoints In Two Phase III Studies     6/12/2017
Zealand Pharma  (ZEAL.CO) Release: New Analysis Shows Soliqua 100/33 Lowered HbA1c By More Than 2% In Patients With Screening Levels Greater Than 9%     6/12/2017
ProLynx Announces PLX039, A Hydrogel-Microsphere Drug Delivery System That Supports Once-Monthly Administration Of A GLP-1 Receptor Agonist     6/12/2017
Amarin (AMRN) Release: Vascepa (Icosapent Ethyl) Showed Reductions In Potentially Atherogenic Lipid Parameters In Statin-Treated Women With Type 2 Diabetes And Persistent High Triglycerides     6/12/2017
Mylan (MYL) And BioCon (BIOCON.NS) Present Clinical Data On Insulin Glargine At The American Diabetes Association's 77th Scientific Sessions     6/12/2017
American Diabetes Association Release: Overweight Boys Who Return To Normal Weight Before Young Adulthood Eliminate Increased Risk Of Developing Type 2 Diabetes As Adults     6/12/2017
American Diabetes Association Release: Severe Obesity In High-Risk Youth Correlates Directly To Increased Incidence Of Type 2 Diabetes     6/12/2017
American Diabetes Association Release: Medication That Inhibits PCSK9 Safely Reduces Cardiovascular Risk In Patients With Type 2 Diabetes     6/12/2017
Valeritas’ V-Go Wearable Insulin Delivery Device Provides Clinical And Economic Benefits, A1C Response And Lower Total Daily Insulin Dose Through Prospective Randomized Trial And Real-World Use By Patients With Type 2 Diabetes     6/12/2017

//-->